Literature DB >> 13940003

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

M F OLIVER, S D ROBERTS, D HAYES, J F PANTRIDGE, M M SUZMAN, I BERSOHN.   

Abstract

Entities:  

Keywords:  ANDROSTERONE; BUTYRATES; CORONARY DISEASE; HYPERCHOLESTEREMIA; HYPERLIPEMIA; PHENINDIONE; WARFARIN

Mesh：

Substances：

Year:  1963        PMID： 13940003     DOI： 10.1016/s0140-6736(63)91025-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".

Authors:  B J PROUT; E A EDWARDS
Journal:  Br Med J       Date:  1963-08-31

2.  Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.

Authors:  V P Rasi; I Torstila
Journal:  Proc R Soc Med       Date:  1976

3.  Warfarin potentiation with bezafibrate.

Authors:  T R Beringer
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

4.  Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

Authors:  T D Bjornsson; P J Meffin; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 5.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

6.  Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.

Authors:  J P Tillement; C Mattei; R Zini
Journal:  Experientia       Date:  1974-05-15

7.  Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

Authors:  C B Hobbs; A L Miller; J H Thornley
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

Review 8.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 9.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

10.  Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

Authors:  G G Duncan; F A Elliott; T G Duncan; J Schatanoff
Journal:  Trans Am Clin Climatol Assoc       Date:  1968
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.